Suheung Capsul - Asset Resilience Ratio
Suheung Capsul (008490) has an Asset Resilience Ratio of 0.99% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Suheung Capsul's Asset Resilience Ratio has changed over time. Check Suheung Capsul strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Suheung Capsul's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Suheung Capsul market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩10.52 Billion | 0.99% |
| Total Liquid Assets | ₩10.52 Billion | 0.99% |
Asset Resilience Insights
- Limited Liquidity: Suheung Capsul maintains only 0.99% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Suheung Capsul Industry Peers by Asset Resilience Ratio
Compare Suheung Capsul's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
JW Pharmaceutical Corp
KO:001067 |
Drug Manufacturers - Specialty & Generic | 8.17% |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
Guilin Sanjin Pharmaceutical Co Ltd
SHE:002275 |
Drug Manufacturers - Specialty & Generic | 14.80% |
|
Fuan Pharmaceutical Group Co
SHE:300194 |
Drug Manufacturers - Specialty & Generic | 1.34% |
|
DRI Healthcare Trust
TO:DHT-U |
Drug Manufacturers - Specialty & Generic | 13.91% |
|
Hainan Shuangcheng Pharmaceut
SHE:002693 |
Drug Manufacturers - Specialty & Generic | 1.03% |
Annual Asset Resilience Ratio for Suheung Capsul (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Suheung Capsul.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.99% | ₩10.52 Billion ≈ $7.13 Million |
₩1.06 Trillion ≈ $719.12 Million |
-0.11pp |
| 2024-12-31 | 1.10% | ₩11.22 Billion ≈ $7.60 Million |
₩1.02 Trillion ≈ $689.68 Million |
+0.12pp |
| 2023-12-31 | 0.98% | ₩9.71 Billion ≈ $6.58 Million |
₩993.74 Billion ≈ $673.44 Million |
-1.32pp |
| 2022-12-31 | 2.30% | ₩21.30 Billion ≈ $14.43 Million |
₩926.42 Billion ≈ $627.82 Million |
+1.33pp |
| 2021-12-31 | 0.97% | ₩7.85 Billion ≈ $5.32 Million |
₩809.95 Billion ≈ $548.89 Million |
-1.47pp |
| 2020-12-31 | 2.44% | ₩18.68 Billion ≈ $12.66 Million |
₩765.99 Billion ≈ $519.10 Million |
+1.29pp |
| 2019-12-31 | 1.15% | ₩8.14 Billion ≈ $5.51 Million |
₩708.86 Billion ≈ $480.39 Million |
+0.87pp |
| 2018-12-31 | 0.28% | ₩1.78 Billion ≈ $1.21 Million |
₩639.10 Billion ≈ $433.11 Million |
+0.03pp |
| 2017-12-31 | 0.25% | ₩1.49 Billion ≈ $1.01 Million |
₩595.29 Billion ≈ $403.42 Million |
-0.68pp |
| 2016-12-31 | 0.93% | ₩5.43 Billion ≈ $3.68 Million |
₩585.89 Billion ≈ $397.05 Million |
+0.20pp |
| 2015-12-31 | 0.73% | ₩4.05 Billion ≈ $2.74 Million |
₩556.75 Billion ≈ $377.30 Million |
-0.01pp |
| 2014-12-31 | 0.73% | ₩3.60 Billion ≈ $2.44 Million |
₩491.21 Billion ≈ $332.88 Million |
-0.06pp |
| 2013-12-31 | 0.79% | ₩3.69 Billion ≈ $2.50 Million |
₩466.55 Billion ≈ $316.17 Million |
+0.45pp |
| 2012-12-31 | 0.34% | ₩1.60 Billion ≈ $1.08 Million |
₩466.47 Billion ≈ $316.12 Million |
+0.31pp |
| 2011-12-31 | 0.03% | ₩138.40 Million ≈ $93.79K |
₩434.23 Billion ≈ $294.27 Million |
-0.08pp |
| 2010-12-31 | 0.11% | ₩410.00 Million ≈ $277.85K |
₩359.76 Billion ≈ $243.80 Million |
-1.94pp |
| 2009-12-31 | 2.05% | ₩5.23 Billion ≈ $3.54 Million |
₩255.24 Billion ≈ $172.97 Million |
-5.26pp |
| 2008-12-31 | 7.31% | ₩18.75 Billion ≈ $12.71 Million |
₩256.71 Billion ≈ $173.97 Million |
-9.87pp |
| 2007-12-31 | 17.18% | ₩33.02 Billion ≈ $22.38 Million |
₩192.26 Billion ≈ $130.29 Million |
+7.19pp |
| 2006-12-31 | 9.99% | ₩16.42 Billion ≈ $11.13 Million |
₩164.35 Billion ≈ $111.38 Million |
-3.29pp |
| 2005-12-31 | 13.28% | ₩21.00 Billion ≈ $14.23 Million |
₩158.14 Billion ≈ $107.17 Million |
+13.18pp |
| 2003-12-31 | 0.10% | ₩105.34 Million ≈ $71.39K |
₩110.72 Billion ≈ $75.03 Million |
-4.18pp |
| 2002-12-31 | 4.27% | ₩4.88 Billion ≈ $3.31 Million |
₩114.22 Billion ≈ $77.41 Million |
+0.99pp |
| 2001-12-31 | 3.29% | ₩4.01 Billion ≈ $2.72 Million |
₩122.19 Billion ≈ $82.81 Million |
-9.78pp |
| 2000-12-31 | 13.06% | ₩17.12 Billion ≈ $11.60 Million |
₩131.06 Billion ≈ $88.81 Million |
-- |
About Suheung Capsul
Suheung Co., Ltd. engages in produces and sells hard and soft capsules. The company provides solid dosage forms, including hard and soft capsule, tablets, powder, granules; fluidity and concentrated liquids; gummy, sticky and water jellies. It offers medical supplies, such as prescription medicines; over-the-counter drugs comprising antipyretic-analgesics, cold medicine, digestive medicine, liver… Read more